|
Rank
|
MeSH Term
|
t+
|
t-
|
b+
|
b-
|
p-value
|
t-ratio
|
b-ratio
|
enrichment folds
|
| 1 | Amyotrophic Lateral Sclerosis | 91 | 77 | 8337 | 17752320 | 2.64e-254 | 0.54 | 0.00 | 1153.9 |
| 2 | Inflammation | 65 | 103 | 55717 | 17704940 | 4.39e-116 | 0.39 | 0.00 | 123.3 |
| 3 | Neurodegenerative Diseases | 28 | 140 | 5168 | 17755489 | 6.23e-68 | 0.17 | 0.00 | 572.8 |
| 4 | Superoxide Dismutase | 35 | 133 | 26196 | 17734461 | 1.12e-63 | 0.21 | 0.00 | 141.2 |
| 5 | Microglia | 22 | 146 | 5795 | 17754862 | 3.80e-50 | 0.13 | 0.00 | 401.3 |
| 6 | Spinal Cord | 31 | 137 | 59022 | 17701635 | 5.85e-44 | 0.18 | 0.00 | 55.5 |
| 7 | Neuroprotective Agents | 20 | 148 | 12617 | 17748040 | 4.00e-38 | 0.12 | 0.00 | 167.6 |
| 8 | Motor Neurons | 22 | 146 | 29190 | 17731467 | 8.56e-35 | 0.13 | 0.00 | 79.7 |
| 9 | Mice, Transgenic | 24 | 144 | 45005 | 17715652 | 2.55e-34 | 0.14 | 0.00 | 56.4 |
| 10 | Disease Models, Animal | 31 | 137 | 130525 | 17630132 | 1.65e-33 | 0.18 | 0.01 | 25.1 |
| 11 | Oxidative Stress | 22 | 146 | 36507 | 17724150 | 1.11e-32 | 0.13 | 0.00 | 63.7 |
| 12 | Inflammation Mediators | 13 | 155 | 7833 | 17752824 | 1.92e-25 | 0.08 | 0.00 | 175.5 |
| 13 | Nerve Degeneration | 15 | 153 | 16657 | 17744000 | 3.24e-25 | 0.09 | 0.00 | 95.2 |
| 14 | Motor Neuron Disease | 10 | 158 | 2643 | 17758014 | 2.00e-23 | 0.06 | 0.00 | 400.0 |
| 15 | Animals | 95 | 73 | 4201052 | 13559605 | 8.61e-20 | 0.57 | 0.24 | 2.4 |
| 16 | Neuroglia | 11 | 157 | 19921 | 17740736 | 1.63e-16 | 0.07 | 0.00 | 58.4 |
| 17 | Disease Progression | 14 | 154 | 53933 | 17706724 | 3.44e-16 | 0.08 | 0.00 | 27.4 |
| 18 | Parkinson Disease | 12 | 156 | 32087 | 17728570 | 6.59e-16 | 0.07 | 0.00 | 39.5 |
| 19 | Alzheimer Disease | 13 | 155 | 44336 | 17716321 | 8.66e-16 | 0.08 | 0.00 | 31.0 |
| 20 | Prostaglandin-Endoperoxide Synthases | 9 | 159 | 12734 | 17747923 | 1.07e-14 | 0.05 | 0.00 | 74.7 |
| 21 | Mice | 36 | 132 | 857637 | 16903020 | 4.47e-14 | 0.21 | 0.05 | 4.4 |
| 22 | Anti-Inflammatory Agents | 11 | 157 | 37893 | 17722764 | 1.66e-13 | 0.07 | 0.00 | 30.7 |
| 23 | Astrocytes | 9 | 159 | 18304 | 17742353 | 2.68e-13 | 0.05 | 0.00 | 52.0 |
| 24 | Encephalitis | 8 | 160 | 11168 | 17749489 | 2.98e-13 | 0.05 | 0.00 | 75.7 |
| 25 | Nervous System Diseases | 10 | 158 | 28283 | 17732374 | 3.14e-13 | 0.06 | 0.00 | 37.4 |
| 26 | Multiple Sclerosis | 10 | 158 | 29352 | 17731305 | 4.51e-13 | 0.06 | 0.00 | 36.0 |
| 27 | Central Nervous System Diseases | 8 | 160 | 13598 | 17747059 | 1.41e-12 | 0.05 | 0.00 | 62.2 |
| 28 | Cyclooxygenase 2 | 7 | 161 | 10778 | 17749879 | 1.84e-11 | 0.04 | 0.00 | 68.7 |
| 29 | Riluzole | 4 | 164 | 528 | 17760129 | 2.54e-11 | 0.02 | 0.00 | 800.9 |
| 30 | Cell Death | 8 | 160 | 20335 | 17740322 | 3.34e-11 | 0.05 | 0.00 | 41.6 |
| 31 | Central Nervous System | 9 | 159 | 32753 | 17727904 | 4.48e-11 | 0.05 | 0.00 | 29.0 |
| 32 | Apoptosis | 13 | 155 | 107008 | 17653649 | 4.91e-11 | 0.08 | 0.01 | 12.8 |
| 33 | Gliosis | 5 | 163 | 2426 | 17758231 | 4.93e-11 | 0.03 | 0.00 | 217.9 |
| 34 | Neurons | 15 | 153 | 163200 | 17597457 | 7.23e-11 | 0.09 | 0.01 | 9.7 |
| 35 | Brain | 19 | 149 | 295379 | 17465278 | 8.07e-11 | 0.11 | 0.02 | 6.8 |
| 36 | Gene Expression Profiling | 8 | 160 | 32773 | 17727884 | 1.38e-09 | 0.05 | 0.00 | 25.8 |
| 37 | Autoimmune Diseases | 8 | 160 | 34418 | 17726239 | 2.01e-09 | 0.05 | 0.00 | 24.6 |
| 38 | Humans | 132 | 36 | 10202172 | 7558485 | 1.16e-08 | 0.79 | 0.57 | 1.4 |
| 39 | Neuromuscular Diseases | 5 | 163 | 7773 | 17752884 | 1.59e-08 | 0.03 | 0.00 | 68.0 |
| 40 | Immunohistochemistry | 13 | 155 | 177182 | 17583475 | 1.95e-08 | 0.08 | 0.01 | 7.8 |
| 41 | Skin Window Technique | 3 | 165 | 576 | 17760081 | 2.67e-08 | 0.02 | 0.00 | 550.6 |
| 42 | Glutamic Acid | 6 | 162 | 23951 | 17736706 | 1.42e-07 | 0.04 | 0.00 | 26.5 |
| 43 | Cell Survival | 9 | 159 | 84639 | 17676018 | 1.52e-07 | 0.05 | 0.00 | 11.2 |
| 44 | Cytokines | 8 | 160 | 62910 | 17697747 | 1.99e-07 | 0.05 | 0.00 | 13.4 |
| 45 | Brain Diseases | 7 | 161 | 42744 | 17717913 | 2.20e-07 | 0.04 | 0.00 | 17.3 |
| 46 | Antioxidants | 7 | 161 | 44005 | 17716652 | 2.67e-07 | 0.04 | 0.00 | 16.8 |
| 47 | Nerve Growth Factors | 5 | 163 | 15281 | 17745376 | 4.41e-07 | 0.03 | 0.00 | 34.6 |
| 48 | Muscular Atrophy | 4 | 164 | 6850 | 17753807 | 6.74e-07 | 0.02 | 0.00 | 61.7 |
| 49 | Myelitis | 3 | 165 | 1951 | 17758706 | 1.02e-06 | 0.02 | 0.00 | 162.6 |
| 50 | Autoimmunity | 4 | 164 | 7717 | 17752940 | 1.08e-06 | 0.02 | 0.00 | 54.8 |
| 51 | Nerve Tissue Proteins | 7 | 161 | 54946 | 17705711 | 1.16e-06 | 0.04 | 0.00 | 13.5 |
| 52 | Up-Regulation | 6 | 162 | 35732 | 17724925 | 1.43e-06 | 0.04 | 0.00 | 17.8 |
| 53 | Survival Rate | 8 | 160 | 83690 | 17676967 | 1.66e-06 | 0.05 | 0.00 | 10.1 |
| 54 | Glial Fibrillary Acidic Protein | 4 | 164 | 9250 | 17751407 | 2.20e-06 | 0.02 | 0.00 | 45.7 |
| 55 | Minocycline | 3 | 165 | 2708 | 17757949 | 2.71e-06 | 0.02 | 0.00 | 117.1 |
| 56 | PPAR gamma | 3 | 165 | 2762 | 17757895 | 2.87e-06 | 0.02 | 0.00 | 114.8 |
| 57 | Rotarod Performance Test | 2 | 166 | 259 | 17760398 | 3.01e-06 | 0.01 | 0.00 | 816.4 |
| 58 | Coculture Techniques | 4 | 164 | 10092 | 17750565 | 3.10e-06 | 0.02 | 0.00 | 41.9 |
| 59 | Tumor Necrosis Factor-alpha | 7 | 161 | 64760 | 17695897 | 3.39e-06 | 0.04 | 0.00 | 11.4 |
| 60 | Isoenzymes | 7 | 161 | 68747 | 17691910 | 4.99e-06 | 0.04 | 0.00 | 10.8 |
| 61 | Muscular Dystrophies | 4 | 164 | 11697 | 17748960 | 5.53e-06 | 0.02 | 0.00 | 36.2 |
| 62 | Polyradiculoneuropathy | 3 | 165 | 3510 | 17757147 | 5.86e-06 | 0.02 | 0.00 | 90.4 |
| 63 | Guam | 2 | 166 | 440 | 17760217 | 8.64e-06 | 0.01 | 0.00 | 480.5 |
| 64 | Motor Activity | 6 | 162 | 50369 | 17710288 | 1.00e-05 | 0.04 | 0.00 | 12.6 |
| 65 | Oligonucleotide Array Sequence Analysis | 5 | 163 | 29527 | 17731130 | 1.07e-05 | 0.03 | 0.00 | 17.9 |
| 66 | Signal Transduction | 9 | 159 | 146440 | 17614217 | 1.28e-05 | 0.05 | 0.01 | 6.5 |
| 67 | Peroxisome Proliferator-Activated Receptors | 2 | 166 | 583 | 17760074 | 1.51e-05 | 0.01 | 0.00 | 362.7 |
| 68 | Mice, Inbred C57BL | 8 | 160 | 115423 | 17645234 | 1.68e-05 | 0.05 | 0.01 | 7.3 |
| 69 | Receptor, Cannabinoid, CB2 | 2 | 166 | 616 | 17760041 | 1.69e-05 | 0.01 | 0.00 | 343.2 |
| 70 | Models, Immunological | 3 | 165 | 5155 | 17755502 | 1.83e-05 | 0.02 | 0.00 | 61.5 |
| 71 | Caspases | 4 | 164 | 18293 | 17742364 | 3.15e-05 | 0.02 | 0.00 | 23.1 |
| 72 | Anterior Horn Cells | 2 | 166 | 846 | 17759811 | 3.18e-05 | 0.01 | 0.00 | 249.9 |
| 73 | Encephalomyelitis, Autoimmune, Experimental | 3 | 165 | 6241 | 17754416 | 3.23e-05 | 0.02 | 0.00 | 50.8 |
| 74 | Huntington Disease | 3 | 165 | 6779 | 17753878 | 4.12e-05 | 0.02 | 0.00 | 46.8 |
| 75 | Microdissection | 2 | 166 | 1010 | 17759647 | 4.52e-05 | 0.01 | 0.00 | 209.3 |
| 76 | Demyelinating Diseases | 3 | 165 | 8078 | 17752579 | 6.91e-05 | 0.02 | 0.00 | 39.3 |
| 77 | Gene Expression | 7 | 161 | 104212 | 17656445 | 6.94e-05 | 0.04 | 0.01 | 7.1 |
| 78 | Cell Count | 5 | 163 | 45178 | 17715479 | 7.93e-05 | 0.03 | 0.00 | 11.7 |
| 79 | Endocannabinoids | 2 | 166 | 1367 | 17759290 | 8.26e-05 | 0.01 | 0.00 | 154.7 |
| 80 | Gene Expression Regulation | 7 | 161 | 111072 | 17649585 | 1.03e-04 | 0.04 | 0.01 | 6.7 |
| 81 | Caspase 1 | 2 | 166 | 1593 | 17759064 | 1.12e-04 | 0.01 | 0.00 | 132.7 |
| 82 | Mice, Knockout | 5 | 163 | 48870 | 17711787 | 1.14e-04 | 0.03 | 0.00 | 10.8 |
| 83 | Free Radicals | 4 | 164 | 25747 | 17734910 | 1.17e-04 | 0.02 | 0.00 | 16.4 |
| 84 | Models, Neurological | 4 | 164 | 26507 | 17734150 | 1.31e-04 | 0.02 | 0.00 | 16.0 |
| 85 | Nitric Oxide | 5 | 163 | 51344 | 17709313 | 1.43e-04 | 0.03 | 0.00 | 10.3 |
| 86 | Toll-Like Receptor 2 | 2 | 166 | 1880 | 17758777 | 1.56e-04 | 0.01 | 0.00 | 112.5 |
| 87 | Excitatory Amino Acid Antagonists | 3 | 165 | 10680 | 17749977 | 1.57e-04 | 0.02 | 0.00 | 29.7 |
| 88 | Myasthenia Gravis | 3 | 165 | 11001 | 17749656 | 1.71e-04 | 0.02 | 0.00 | 28.8 |
| 89 | Cyclooxygenase Inhibitors | 3 | 165 | 12497 | 17748160 | 2.48e-04 | 0.02 | 0.00 | 25.4 |
| 90 | Mice, Neurologic Mutants | 2 | 166 | 3331 | 17757326 | 4.84e-04 | 0.01 | 0.00 | 63.5 |
| 91 | Parasystole | 1 | 167 | 54 | 17760603 | 5.20e-04 | 0.01 | 0.00 | 1957.7 |
| 92 | Peripheral Nervous System Diseases | 3 | 165 | 16296 | 17744361 | 5.36e-04 | 0.02 | 0.00 | 19.5 |
| 93 | RNA, Messenger | 9 | 159 | 241499 | 17519158 | 5.41e-04 | 0.05 | 0.01 | 3.9 |
| 94 | Cannabinoids | 2 | 166 | 3544 | 17757113 | 5.47e-04 | 0.01 | 0.00 | 59.7 |
| 95 | Drug Delivery Systems | 3 | 165 | 16877 | 17743780 | 5.93e-04 | 0.02 | 0.00 | 18.8 |
| 96 | Neuritis | 2 | 166 | 3878 | 17756779 | 6.53e-04 | 0.01 | 0.00 | 54.5 |
| 97 | Cerebrospinal Fluid Proteins | 2 | 166 | 3878 | 17756779 | 6.53e-04 | 0.01 | 0.00 | 54.5 |
| 98 | Thalidomide | 2 | 166 | 4219 | 17756438 | 7.72e-04 | 0.01 | 0.00 | 50.1 |
| 99 | Macrophages | 5 | 163 | 75643 | 17685014 | 8.29e-04 | 0.03 | 0.00 | 7.0 |
| 100 | Cell Communication | 3 | 165 | 19011 | 17741646 | 8.35e-04 | 0.02 | 0.00 | 16.7 |
| 101 | Lipopolysaccharides | 4 | 164 | 43766 | 17716891 | 8.56e-04 | 0.02 | 0.00 | 9.7 |
| 102 | Reverse Transcriptase Polymerase Chain Reaction | 5 | 163 | 77683 | 17682974 | 9.32e-04 | 0.03 | 0.00 | 6.8 |
| 103 | Dinoprostone | 3 | 165 | 20602 | 17740055 | 0.001 | 0.02 | 0.00 | 15.4 |
| 104 | Chemokine CCL2 | 2 | 166 | 4975 | 17755682 | 0.001 | 0.01 | 0.00 | 42.5 |
| 105 | NADPH Oxidase | 2 | 166 | 4980 | 17755677 | 0.001 | 0.01 | 0.00 | 42.5 |
| 106 | Biological Markers | 5 | 163 | 80764 | 17679893 | 0.001 | 0.03 | 0.00 | 6.5 |
| 107 | Cell Migration Inhibition | 2 | 166 | 5205 | 17755452 | 0.001 | 0.01 | 0.00 | 40.6 |
| 108 | T-Lymphocytes | 6 | 162 | 122168 | 17638489 | 0.001 | 0.04 | 0.01 | 5.2 |
| 109 | Thiazolidinediones | 2 | 166 | 5228 | 17755429 | 0.001 | 0.01 | 0.00 | 40.4 |
| 110 | Insulin-Like Growth Factor I | 3 | 165 | 21911 | 17738746 | 0.001 | 0.02 | 0.00 | 14.5 |
| 111 | Myositis | 2 | 166 | 5730 | 17754927 | 0.001 | 0.01 | 0.00 | 36.9 |
| 112 | Amyloid beta-Protein Precursor | 2 | 166 | 5764 | 17754893 | 0.001 | 0.01 | 0.00 | 36.7 |
| 113 | Collagen Type XI | 1 | 167 | 158 | 17760499 | 0.002 | 0.01 | 0.00 | 669.1 |
| 114 | Membrane Glycoproteins | 4 | 164 | 51135 | 17709522 | 0.002 | 0.02 | 0.00 | 8.3 |
| 115 | Metallothionein | 2 | 166 | 6416 | 17754241 | 0.002 | 0.01 | 0.00 | 33.0 |
| 116 | Prostaglandins | 3 | 165 | 24815 | 17735842 | 0.002 | 0.02 | 0.00 | 12.8 |
| 117 | Mutation | 8 | 160 | 233839 | 17526818 | 0.002 | 0.05 | 0.01 | 3.6 |
| 118 | Glucose Transport Proteins, Facilitative | 1 | 167 | 219 | 17760438 | 0.002 | 0.01 | 0.00 | 482.7 |
| 119 | PAX7 Transcription Factor | 1 | 167 | 224 | 17760433 | 0.002 | 0.01 | 0.00 | 472.0 |
| 120 | Stroke | 3 | 165 | 26850 | 17733807 | 0.002 | 0.02 | 0.00 | 11.8 |
| 121 | Oxidants | 2 | 166 | 7287 | 17753370 | 0.002 | 0.01 | 0.00 | 29.0 |
| 122 | Lumbosacral Region | 2 | 166 | 7645 | 17753012 | 0.002 | 0.01 | 0.00 | 27.7 |
| 123 | Neurogenic Inflammation | 1 | 167 | 288 | 17760369 | 0.003 | 0.01 | 0.00 | 367.1 |
| 124 | Spinal Nerve Roots | 2 | 166 | 8126 | 17752531 | 0.003 | 0.01 | 0.00 | 26.0 |
| 125 | Nuclease Protection Assays | 1 | 167 | 327 | 17760330 | 0.003 | 0.01 | 0.00 | 323.3 |
| 126 | Macrophage Activation | 2 | 166 | 8716 | 17751941 | 0.003 | 0.01 | 0.00 | 24.3 |
| 127 | Oligoclonal Bands | 1 | 167 | 353 | 17760304 | 0.003 | 0.01 | 0.00 | 299.5 |
| 128 | Spinal Cord Diseases | 2 | 166 | 8930 | 17751727 | 0.003 | 0.01 | 0.00 | 23.7 |
| 129 | Tumor Necrosis Factor Decoy Receptors | 1 | 167 | 357 | 17760300 | 0.003 | 0.01 | 0.00 | 296.1 |
| 130 | Animals, Genetically Modified | 2 | 166 | 9477 | 17751180 | 0.004 | 0.01 | 0.00 | 22.3 |
| 131 | Satellite Cells, Skeletal Muscle | 1 | 167 | 403 | 17760254 | 0.004 | 0.01 | 0.00 | 262.3 |
| 132 | Longevity | 2 | 166 | 9887 | 17750770 | 0.004 | 0.01 | 0.00 | 21.4 |
| 133 | Agrin | 1 | 167 | 474 | 17760183 | 0.004 | 0.01 | 0.00 | 223.0 |
| 134 | Receptors, Tumor Necrosis Factor | 2 | 166 | 10621 | 17750036 | 0.005 | 0.01 | 0.00 | 19.9 |
| 135 | Caspase 3 | 2 | 166 | 11123 | 17749534 | 0.005 | 0.01 | 0.00 | 19.0 |
| 136 | Axons | 3 | 165 | 36509 | 17724148 | 0.005 | 0.02 | 0.00 | 8.7 |
| 137 | Refsum Disease | 1 | 167 | 565 | 17760092 | 0.005 | 0.01 | 0.00 | 187.1 |
| 138 | Fas-Associated Death Domain Protein | 1 | 167 | 613 | 17760044 | 0.006 | 0.01 | 0.00 | 172.5 |
| 139 | Anti-Inflammatory Agents, Non-Steroidal | 3 | 165 | 38640 | 17722017 | 0.006 | 0.02 | 0.00 | 8.2 |
| 140 | Multiple Sclerosis, Chronic Progressive | 1 | 167 | 712 | 17759945 | 0.007 | 0.01 | 0.00 | 148.5 |
| 141 | Antigens, CD | 3 | 165 | 40180 | 17720477 | 0.007 | 0.02 | 0.00 | 7.9 |
| 142 | Eye Infections, Parasitic | 1 | 167 | 762 | 17759895 | 0.007 | 0.01 | 0.00 | 138.7 |
| 143 | Poliomyelitis | 2 | 166 | 13281 | 17747376 | 0.007 | 0.01 | 0.00 | 15.9 |
| 144 | Toxoplasmosis, Cerebral | 1 | 167 | 867 | 17759790 | 0.008 | 0.01 | 0.00 | 121.9 |
| 145 | Meningitis, Cryptococcal | 1 | 167 | 897 | 17759760 | 0.008 | 0.01 | 0.00 | 117.9 |
| 146 | Receptors, Glucagon | 1 | 167 | 917 | 17759740 | 0.009 | 0.01 | 0.00 | 115.3 |
| 147 | Tumor Necrosis Factors | 1 | 167 | 987 | 17759670 | 0.009 | 0.01 | 0.00 | 107.1 |
| 148 | Carnosine | 1 | 167 | 1003 | 17759654 | 0.009 | 0.01 | 0.00 | 105.4 |
| 149 | Blotting, Western | 4 | 164 | 86974 | 17673683 | 0.010 | 0.02 | 0.00 | 4.9 |
| 150 | Receptors, Interleukin-4 | 1 | 167 | 1070 | 17759587 | 0.010 | 0.01 | 0.00 | 98.8 |
| 151 | Dinitrofluorobenzene | 1 | 167 | 1090 | 17759567 | 0.010 | 0.01 | 0.00 | 97.0 |
| 152 | Ciliary Neurotrophic Factor | 1 | 167 | 1188 | 17759469 | 0.011 | 0.01 | 0.00 | 89.0 |
| 153 | Facial Nerve Injuries | 1 | 167 | 1190 | 17759467 | 0.011 | 0.01 | 0.00 | 88.8 |
| 154 | Quinolinic Acid | 1 | 167 | 1193 | 17759464 | 0.011 | 0.01 | 0.00 | 88.6 |
| 155 | Neuronal Ceroid-Lipofuscinoses | 1 | 167 | 1234 | 17759423 | 0.012 | 0.01 | 0.00 | 85.7 |
| 156 | Flavanones | 1 | 167 | 1258 | 17759399 | 0.012 | 0.01 | 0.00 | 84.0 |
| 157 | Neuromuscular Junction | 2 | 166 | 17268 | 17743389 | 0.012 | 0.01 | 0.00 | 12.2 |
| 158 | Hypochlorous Acid | 1 | 167 | 1269 | 17759388 | 0.012 | 0.01 | 0.00 | 83.3 |
| 159 | Paraparesis, Tropical Spastic | 1 | 167 | 1283 | 17759374 | 0.012 | 0.01 | 0.00 | 82.4 |
| 160 | Vascular Endothelial Growth Factor A | 2 | 166 | 17404 | 17743253 | 0.012 | 0.01 | 0.00 | 12.1 |
| 161 | Muscular Diseases | 2 | 166 | 17424 | 17743233 | 0.012 | 0.01 | 0.00 | 12.1 |
| 162 | Tacrine | 1 | 167 | 1295 | 17759362 | 0.012 | 0.01 | 0.00 | 81.6 |
| 163 | Monokines | 1 | 167 | 1300 | 17759357 | 0.012 | 0.01 | 0.00 | 81.3 |
| 164 | Caloric Restriction | 1 | 167 | 1313 | 17759344 | 0.012 | 0.01 | 0.00 | 80.5 |
| 165 | Receptors, Tumor Necrosis Factor, Type II | 1 | 167 | 1327 | 17759330 | 0.012 | 0.01 | 0.00 | 79.7 |
| 166 | Immunity, Natural | 2 | 166 | 17723 | 17742934 | 0.013 | 0.01 | 0.00 | 11.9 |
| 167 | Mitochondrial Diseases | 1 | 167 | 1338 | 17759319 | 0.013 | 0.01 | 0.00 | 79.0 |
| 168 | Aging | 5 | 163 | 145249 | 17615408 | 0.013 | 0.03 | 0.01 | 3.6 |
| 169 | Membrane Proteins | 4 | 164 | 95217 | 17665440 | 0.013 | 0.02 | 0.01 | 4.4 |
| 170 | Polymyositis | 1 | 167 | 1413 | 17759244 | 0.013 | 0.01 | 0.00 | 74.8 |
| 171 | Myelin-Associated Glycoprotein | 1 | 167 | 1455 | 17759202 | 0.014 | 0.01 | 0.00 | 72.7 |
| 172 | Dose-Response Relationship, Drug | 7 | 161 | 265812 | 17494845 | 0.014 | 0.04 | 0.01 | 2.8 |
| 173 | Receptors, Prostaglandin E | 1 | 167 | 1508 | 17759149 | 0.014 | 0.01 | 0.00 | 70.1 |
| 174 | Immunotherapy, Active | 1 | 167 | 1714 | 17758943 | 0.016 | 0.01 | 0.00 | 61.7 |
| 175 | Muscular Atrophy, Spinal | 1 | 167 | 1742 | 17758915 | 0.016 | 0.01 | 0.00 | 60.7 |
| 176 | Streptolysins | 1 | 167 | 1788 | 17758869 | 0.017 | 0.01 | 0.00 | 59.1 |
| 177 | Neopterin | 1 | 167 | 1802 | 17758855 | 0.017 | 0.01 | 0.00 | 58.7 |
| 178 | Mast Cells | 2 | 166 | 20839 | 17739818 | 0.017 | 0.01 | 0.00 | 10.1 |
| 179 | Neurotransmitter Agents | 2 | 166 | 20912 | 17739745 | 0.017 | 0.01 | 0.00 | 10.1 |
| 180 | Presenilin-1 | 1 | 167 | 1822 | 17758835 | 0.017 | 0.01 | 0.00 | 58.0 |
| 181 | Kynurenine | 1 | 167 | 1830 | 17758827 | 0.017 | 0.01 | 0.00 | 57.8 |
| 182 | Polyradiculopathy | 1 | 167 | 1871 | 17758786 | 0.018 | 0.01 | 0.00 | 56.5 |
| 183 | Glutathione Disulfide | 1 | 167 | 1917 | 17758740 | 0.018 | 0.01 | 0.00 | 55.1 |
| 184 | Drug Design | 2 | 166 | 21608 | 17739049 | 0.018 | 0.01 | 0.00 | 9.8 |
| 185 | Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 167 | 1988 | 17758669 | 0.019 | 0.01 | 0.00 | 53.2 |
| 186 | Charcot-Marie-Tooth Disease | 1 | 167 | 2018 | 17758639 | 0.019 | 0.01 | 0.00 | 52.4 |
| 187 | Cytoprotection | 1 | 167 | 2033 | 17758624 | 0.019 | 0.01 | 0.00 | 52.0 |
| 188 | Vertebrobasilar Insufficiency | 1 | 167 | 2041 | 17758616 | 0.019 | 0.01 | 0.00 | 51.8 |
| 189 | Metalloporphyrins | 1 | 167 | 2077 | 17758580 | 0.019 | 0.01 | 0.00 | 50.9 |
| 190 | Nootropic Agents | 1 | 167 | 2091 | 17758566 | 0.020 | 0.01 | 0.00 | 50.6 |
| 191 | Cell Shape | 1 | 167 | 2111 | 17758546 | 0.020 | 0.01 | 0.00 | 50.1 |
| 192 | NF-kappa B | 2 | 166 | 22757 | 17737900 | 0.020 | 0.01 | 0.00 | 9.3 |
| 193 | Receptors, Cannabinoid | 1 | 167 | 2149 | 17758508 | 0.020 | 0.01 | 0.00 | 49.2 |
| 194 | Protein Hydrolysates | 1 | 167 | 2168 | 17758489 | 0.020 | 0.01 | 0.00 | 48.8 |
| 195 | Hematopoietic Cell Growth Factors | 1 | 167 | 2206 | 17758451 | 0.021 | 0.01 | 0.00 | 47.9 |
| 196 | Receptors, Tumor Necrosis Factor, Type I | 1 | 167 | 2209 | 17758448 | 0.021 | 0.01 | 0.00 | 47.9 |
| 197 | Receptors, Vascular Endothelial Growth Factor | 1 | 167 | 2218 | 17758439 | 0.021 | 0.01 | 0.00 | 47.7 |
| 198 | Arrhythmia, Sinus | 1 | 167 | 2318 | 17758339 | 0.022 | 0.01 | 0.00 | 45.6 |
| 199 | Prostaglandin D2 | 1 | 167 | 2388 | 17758269 | 0.022 | 0.01 | 0.00 | 44.3 |
| 200 | Receptors, Prostaglandin | 1 | 167 | 2421 | 17758236 | 0.023 | 0.01 | 0.00 | 43.7 |
| 201 | Scrapie | 1 | 167 | 2445 | 17758212 | 0.023 | 0.01 | 0.00 | 43.2 |
| 202 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 167 | 2513 | 17758144 | 0.024 | 0.01 | 0.00 | 42.1 |
| 203 | Brain Ischemia | 2 | 166 | 25028 | 17735629 | 0.024 | 0.01 | 0.00 | 8.4 |
| 204 | Desmin | 1 | 167 | 2574 | 17758083 | 0.024 | 0.01 | 0.00 | 41.1 |
| 205 | Hydantoins | 1 | 167 | 2576 | 17758081 | 0.024 | 0.01 | 0.00 | 41.0 |
| 206 | Chemokine CCL5 | 1 | 167 | 2623 | 17758034 | 0.025 | 0.01 | 0.00 | 40.3 |
| 207 | HLA Antigens | 2 | 166 | 25475 | 17735182 | 0.025 | 0.01 | 0.00 | 8.3 |
| 208 | Syringomyelia | 1 | 167 | 2652 | 17758005 | 0.025 | 0.01 | 0.00 | 39.9 |
| 209 | Erythropoietin, Recombinant | 1 | 167 | 2667 | 17757990 | 0.025 | 0.01 | 0.00 | 39.6 |
| 210 | AIDS Dementia Complex | 1 | 167 | 2674 | 17757983 | 0.025 | 0.01 | 0.00 | 39.5 |
| 211 | Survival | 1 | 167 | 2725 | 17757932 | 0.025 | 0.01 | 0.00 | 38.8 |
| 212 | Kaplan-Meiers Estimate | 1 | 167 | 2737 | 17757920 | 0.026 | 0.01 | 0.00 | 38.6 |
| 213 | Eicosanoids | 1 | 167 | 2739 | 17757918 | 0.026 | 0.01 | 0.00 | 38.6 |
| 214 | Rats, Sprague-Dawley | 5 | 163 | 174228 | 17586429 | 0.026 | 0.03 | 0.01 | 3.0 |
| 215 | Brain Neoplasms | 3 | 165 | 66509 | 17694148 | 0.026 | 0.02 | 0.00 | 4.8 |
| 216 | Drug Evaluation, Preclinical | 2 | 166 | 26253 | 17734404 | 0.026 | 0.01 | 0.00 | 8.1 |
| 217 | Thioredoxins | 1 | 167 | 2797 | 17757860 | 0.026 | 0.01 | 0.00 | 37.8 |
| 218 | Central Nervous System Neoplasms | 1 | 167 | 2799 | 17757858 | 0.026 | 0.01 | 0.00 | 37.8 |
| 219 | Defective Viruses | 1 | 167 | 2809 | 17757848 | 0.026 | 0.01 | 0.00 | 37.6 |
| 220 | Protein Array Analysis | 1 | 167 | 2840 | 17757817 | 0.027 | 0.01 | 0.00 | 37.2 |
| 221 | Dementia | 2 | 166 | 26559 | 17734098 | 0.027 | 0.01 | 0.00 | 8.0 |
| 222 | Mitochondria | 3 | 165 | 67391 | 17693266 | 0.027 | 0.02 | 0.00 | 4.7 |
| 223 | Cyclooxygenase 1 | 1 | 167 | 2861 | 17757796 | 0.027 | 0.01 | 0.00 | 37.0 |
| 224 | Guanine Nucleotide Exchange Factors | 1 | 167 | 2870 | 17757787 | 0.027 | 0.01 | 0.00 | 36.8 |
| 225 | Mesenchymal Stem Cells | 1 | 167 | 2995 | 17757662 | 0.028 | 0.01 | 0.00 | 35.3 |
| 226 | Blinking | 1 | 167 | 3001 | 17757656 | 0.028 | 0.01 | 0.00 | 35.2 |
| 227 | Gene Therapy | 2 | 166 | 27431 | 17733226 | 0.028 | 0.01 | 0.00 | 7.7 |
| 228 | Parkinsonian Disorders | 1 | 167 | 3030 | 17757627 | 0.028 | 0.01 | 0.00 | 34.9 |
| 229 | Polymorphism, Genetic | 3 | 165 | 68974 | 17691683 | 0.028 | 0.02 | 0.00 | 4.6 |
| 230 | Hyperkinesis | 1 | 167 | 3080 | 17757577 | 0.029 | 0.01 | 0.00 | 34.3 |
| 231 | Thiocarbamates | 1 | 167 | 3108 | 17757549 | 0.029 | 0.01 | 0.00 | 34.0 |
| 232 | Lipoxygenase | 1 | 167 | 3167 | 17757490 | 0.030 | 0.01 | 0.00 | 33.4 |
| 233 | Integrases | 1 | 167 | 3211 | 17757446 | 0.030 | 0.01 | 0.00 | 32.9 |
| 234 | Virus Diseases | 2 | 166 | 28335 | 17732322 | 0.030 | 0.01 | 0.00 | 7.5 |
| 235 | Heme Oxygenase (Decyclizing) | 1 | 167 | 3226 | 17757431 | 0.030 | 0.01 | 0.00 | 32.8 |
| 236 | Antigens, Differentiation, Myelomonocytic | 1 | 167 | 3248 | 17757409 | 0.030 | 0.01 | 0.00 | 32.5 |
| 237 | Interleukin-6 | 2 | 166 | 28565 | 17732092 | 0.030 | 0.01 | 0.00 | 7.4 |
| 238 | Peroneal Nerve | 1 | 167 | 3289 | 17757368 | 0.031 | 0.01 | 0.00 | 32.1 |
| 239 | Paraproteinemias | 1 | 167 | 3321 | 17757336 | 0.031 | 0.01 | 0.00 | 31.8 |
| 240 | Sex Characteristics | 2 | 166 | 29172 | 17731485 | 0.032 | 0.01 | 0.00 | 7.2 |
| 241 | Enzyme Induction | 2 | 166 | 29253 | 17731404 | 0.032 | 0.01 | 0.00 | 7.2 |
| 242 | Calcineurin | 1 | 167 | 3479 | 17757178 | 0.032 | 0.01 | 0.00 | 30.4 |
| 243 | Respiratory Muscles | 1 | 167 | 3538 | 17757119 | 0.033 | 0.01 | 0.00 | 29.9 |
| 244 | Psychomotor Performance | 2 | 166 | 30047 | 17730610 | 0.033 | 0.01 | 0.00 | 7.0 |
| 245 | Tissue Fixation | 1 | 167 | 3589 | 17757068 | 0.033 | 0.01 | 0.00 | 29.5 |
| 246 | Transglutaminases | 1 | 167 | 3595 | 17757062 | 0.033 | 0.01 | 0.00 | 29.4 |
| 247 | Myosin Heavy Chains | 1 | 167 | 3624 | 17757033 | 0.034 | 0.01 | 0.00 | 29.2 |
| 248 | Microscopy, Video | 1 | 167 | 3630 | 17757027 | 0.034 | 0.01 | 0.00 | 29.1 |
| 249 | Antigens, CD40 | 1 | 167 | 3650 | 17757007 | 0.034 | 0.01 | 0.00 | 29.0 |
| 250 | Scapula | 1 | 167 | 3654 | 17757003 | 0.034 | 0.01 | 0.00 | 28.9 |
| 251 | Pyridazines | 1 | 167 | 3789 | 17756868 | 0.035 | 0.01 | 0.00 | 27.9 |
| 252 | Azepines | 1 | 167 | 3986 | 17756671 | 0.037 | 0.01 | 0.00 | 26.5 |
| 253 | Interleukin-1 | 2 | 166 | 31926 | 17728731 | 0.037 | 0.01 | 0.00 | 6.6 |
| 254 | Molecular Structure | 3 | 165 | 77946 | 17682711 | 0.038 | 0.02 | 0.00 | 4.1 |
| 255 | Tyrosine | 2 | 166 | 33060 | 17727597 | 0.040 | 0.01 | 0.00 | 6.4 |
| 256 | Postmortem Changes | 1 | 167 | 4486 | 17756171 | 0.042 | 0.01 | 0.00 | 23.6 |
| 257 | Toll-Like Receptors | 1 | 167 | 4501 | 17756156 | 0.042 | 0.01 | 0.00 | 23.5 |
| 258 | Pharmacogenetics | 1 | 167 | 4503 | 17756154 | 0.042 | 0.01 | 0.00 | 23.5 |
| 259 | Triterpenes | 1 | 167 | 4564 | 17756093 | 0.042 | 0.01 | 0.00 | 23.2 |
| 260 | Cells, Cultured | 7 | 161 | 337633 | 17423024 | 0.043 | 0.04 | 0.02 | 2.2 |
| 261 | Glutathione | 2 | 166 | 34475 | 17726182 | 0.043 | 0.01 | 0.00 | 6.1 |
| 262 | Electrophoretic Mobility Shift Assay | 1 | 167 | 4779 | 17755878 | 0.044 | 0.01 | 0.00 | 22.1 |
| 263 | Discriminant Analysis | 1 | 167 | 4784 | 17755873 | 0.044 | 0.01 | 0.00 | 22.1 |
| 264 | Retinitis Pigmentosa | 1 | 167 | 4793 | 17755864 | 0.044 | 0.01 | 0.00 | 22.1 |
| 265 | Cyclooxygenase 2 Inhibitors | 1 | 167 | 4845 | 17755812 | 0.045 | 0.01 | 0.00 | 21.8 |
| 266 | Statistics, Nonparametric | 2 | 166 | 35426 | 17725231 | 0.045 | 0.01 | 0.00 | 6.0 |
| 267 | Bites and Stings | 1 | 167 | 5066 | 17755591 | 0.047 | 0.01 | 0.00 | 20.9 |
| 268 | Endoscopes | 1 | 167 | 5093 | 17755564 | 0.047 | 0.01 | 0.00 | 20.8 |
| 269 | Brain-Derived Neurotrophic Factor | 1 | 167 | 5101 | 17755556 | 0.047 | 0.01 | 0.00 | 20.7 |
| 270 | Syndrome | 3 | 165 | 84811 | 17675846 | 0.047 | 0.02 | 0.00 | 3.7 |
| 271 | Fas Ligand Protein | 1 | 167 | 5155 | 17755502 | 0.048 | 0.01 | 0.00 | 20.5 |
| 272 | Osteochondritis | 1 | 167 | 5279 | 17755378 | 0.049 | 0.01 | 0.00 | 20.0 |
| 273 | Child, Preschool | 1 | 167 | 596647 | 17164010 | 0.049 | 0.01 | 0.03 | 0.2 |
| 274 | Receptors, Glutamate | 1 | 167 | 5340 | 17755317 | 0.049 | 0.01 | 0.00 | 19.8 |
| 275 | Intermediate Filament Proteins | 1 | 167 | 5390 | 17755267 | 0.050 | 0.01 | 0.00 | 19.6 |
| 276 | Enzyme Inhibitors | 3 | 165 | 87140 | 17673517 | 0.051 | 0.02 | 0.00 | 3.6 |
| 277 | Child | 4 | 164 | 1087153 | 16673504 | 0.051 | 0.02 | 0.06 | 0.4 |
| 278 | Adult | 19 | 149 | 3034578 | 14726079 | 0.051 | 0.11 | 0.17 | 0.7 |
| 279 | Ubiquitin-Protein Ligases | 1 | 167 | 5511 | 17755146 | 0.051 | 0.01 | 0.00 | 19.2 |
| 280 | Interleukin-3 | 1 | 167 | 5665 | 17754992 | 0.052 | 0.01 | 0.00 | 18.7 |
| 281 | Prosencephalon | 1 | 167 | 5669 | 17754988 | 0.052 | 0.01 | 0.00 | 18.6 |
| 282 | Behcet Syndrome | 1 | 167 | 5742 | 17754915 | 0.053 | 0.01 | 0.00 | 18.4 |
| 283 | In Situ Hybridization | 2 | 166 | 39415 | 17721242 | 0.054 | 0.01 | 0.00 | 5.4 |
| 284 | Immunologic Factors | 1 | 167 | 6026 | 17754631 | 0.055 | 0.01 | 0.00 | 17.5 |
| 285 | Estrogens | 2 | 166 | 41249 | 17719408 | 0.059 | 0.01 | 0.00 | 5.1 |
| 286 | Cathepsins | 1 | 167 | 6433 | 17754224 | 0.059 | 0.01 | 0.00 | 16.4 |
| 287 | Atherosclerosis | 1 | 167 | 6441 | 17754216 | 0.059 | 0.01 | 0.00 | 16.4 |
| 288 | Gene Targeting | 1 | 167 | 6494 | 17754163 | 0.060 | 0.01 | 0.00 | 16.3 |
| 289 | Plasmapheresis | 1 | 167 | 6522 | 17754135 | 0.060 | 0.01 | 0.00 | 16.2 |
| 290 | Creatine | 1 | 167 | 6573 | 17754084 | 0.060 | 0.01 | 0.00 | 16.1 |
| 291 | Genetic Predisposition to Disease | 2 | 166 | 42031 | 17718626 | 0.061 | 0.01 | 0.00 | 5.0 |
| 292 | Axonal Transport | 1 | 167 | 6663 | 17753994 | 0.061 | 0.01 | 0.00 | 15.9 |
| 293 | Metabolic Diseases | 1 | 167 | 6818 | 17753839 | 0.062 | 0.01 | 0.00 | 15.5 |
| 294 | Ophthalmoplegia | 1 | 167 | 6838 | 17753819 | 0.063 | 0.01 | 0.00 | 15.5 |
| 295 | Neoplasm Proteins | 2 | 166 | 43196 | 17717461 | 0.064 | 0.01 | 0.00 | 4.9 |
| 296 | NADH, NADPH Oxidoreductases | 1 | 167 | 7016 | 17753641 | 0.064 | 0.01 | 0.00 | 15.1 |
| 297 | Acetylcysteine | 1 | 167 | 7017 | 17753640 | 0.064 | 0.01 | 0.00 | 15.1 |
| 298 | Complement Activation | 1 | 167 | 7337 | 17753320 | 0.067 | 0.01 | 0.00 | 14.4 |
| 299 | S100 Proteins | 1 | 167 | 7370 | 17753287 | 0.067 | 0.01 | 0.00 | 14.3 |
| 300 | Spinal Cord Compression | 1 | 167 | 7731 | 17752926 | 0.071 | 0.01 | 0.00 | 13.7 |
| 301 | Receptors, G-Protein-Coupled | 1 | 167 | 7864 | 17752793 | 0.072 | 0.01 | 0.00 | 13.4 |
| 302 | Gangliosides | 1 | 167 | 7882 | 17752775 | 0.072 | 0.01 | 0.00 | 13.4 |
| 303 | Bradycardia | 1 | 167 | 7970 | 17752687 | 0.073 | 0.01 | 0.00 | 13.3 |
| 304 | HSP70 Heat-Shock Proteins | 1 | 167 | 8103 | 17752554 | 0.074 | 0.01 | 0.00 | 13.0 |
| 305 | Technology, Pharmaceutical | 1 | 167 | 8149 | 17752508 | 0.074 | 0.01 | 0.00 | 13.0 |
| 306 | Muscle Fibers | 1 | 167 | 8157 | 17752500 | 0.074 | 0.01 | 0.00 | 13.0 |
| 307 | Phospholipases A2 | 1 | 167 | 8185 | 17752472 | 0.075 | 0.01 | 0.00 | 12.9 |
| 308 | Musculoskeletal Equilibrium | 1 | 167 | 8186 | 17752471 | 0.075 | 0.01 | 0.00 | 12.9 |
| 309 | Stem Cell Transplantation | 1 | 167 | 8325 | 17752332 | 0.076 | 0.01 | 0.00 | 12.7 |
| 310 | Proteasome Endopeptidase Complex | 1 | 167 | 8585 | 17752072 | 0.078 | 0.01 | 0.00 | 12.3 |
| 311 | Neurotoxins | 1 | 167 | 8693 | 17751964 | 0.079 | 0.01 | 0.00 | 12.2 |
| 312 | Vacuoles | 1 | 167 | 8753 | 17751904 | 0.079 | 0.01 | 0.00 | 12.1 |
| 313 | Pyrrolidines | 1 | 167 | 8761 | 17751896 | 0.080 | 0.01 | 0.00 | 12.1 |
| 314 | Pigment Epithelium of Eye | 1 | 167 | 8810 | 17751847 | 0.080 | 0.01 | 0.00 | 12.0 |
| 315 | Oxidation-Reduction | 3 | 165 | 106294 | 17654363 | 0.081 | 0.02 | 0.01 | 3.0 |
| 316 | Immune System | 1 | 167 | 9031 | 17751626 | 0.082 | 0.01 | 0.00 | 11.7 |
| 317 | Antigens, CD3 | 1 | 167 | 9130 | 17751527 | 0.083 | 0.01 | 0.00 | 11.6 |
| 318 | Receptors, Neurotransmitter | 1 | 167 | 9139 | 17751518 | 0.083 | 0.01 | 0.00 | 11.6 |
| 319 | Vasoactive Intestinal Peptide | 1 | 167 | 9220 | 17751437 | 0.084 | 0.01 | 0.00 | 11.5 |
| 320 | Neovascularization, Physiologic | 1 | 167 | 9238 | 17751419 | 0.084 | 0.01 | 0.00 | 11.4 |
| 321 | Sulfones | 1 | 167 | 9283 | 17751374 | 0.084 | 0.01 | 0.00 | 11.4 |
| 322 | Somatosensory Cortex | 1 | 167 | 9391 | 17751266 | 0.085 | 0.01 | 0.00 | 11.3 |
| 323 | Transgenes | 1 | 167 | 9443 | 17751214 | 0.085 | 0.01 | 0.00 | 11.2 |
| 324 | Walking | 1 | 167 | 9461 | 17751196 | 0.086 | 0.01 | 0.00 | 11.2 |
| 325 | Eyelids | 1 | 167 | 9471 | 17751186 | 0.086 | 0.01 | 0.00 | 11.2 |
| 326 | Microtubule-Associated Proteins | 1 | 167 | 9771 | 17750886 | 0.088 | 0.01 | 0.00 | 10.8 |
| 327 | Intraoperative Period | 1 | 167 | 9773 | 17750884 | 0.088 | 0.01 | 0.00 | 10.8 |
| 328 | Death, Sudden | 1 | 167 | 9789 | 17750868 | 0.088 | 0.01 | 0.00 | 10.8 |
| 329 | Calcium Signaling | 1 | 167 | 9854 | 17750803 | 0.089 | 0.01 | 0.00 | 10.7 |
| 330 | Death | 1 | 167 | 9893 | 17750764 | 0.089 | 0.01 | 0.00 | 10.7 |
| 331 | T-Lymphocytes, Helper-Inducer | 1 | 167 | 10033 | 17750624 | 0.091 | 0.01 | 0.00 | 10.5 |
| 332 | Immunosuppressive Agents | 2 | 166 | 53198 | 17707459 | 0.091 | 0.01 | 0.00 | 4.0 |
| 333 | Nitric Oxide Synthase Type II | 1 | 167 | 10214 | 17750443 | 0.092 | 0.01 | 0.00 | 10.4 |
| 334 | Proteomics | 1 | 167 | 10219 | 17750438 | 0.092 | 0.01 | 0.00 | 10.3 |
| 335 | Models, Molecular | 3 | 165 | 112805 | 17647852 | 0.092 | 0.02 | 0.01 | 2.8 |
| 336 | In Situ Nick-End Labeling | 1 | 167 | 10259 | 17750398 | 0.093 | 0.01 | 0.00 | 10.3 |
| 337 | Peroxidase | 1 | 167 | 10364 | 17750293 | 0.093 | 0.01 | 0.00 | 10.2 |
| 338 | Adolescent | 6 | 162 | 1229525 | 16531132 | 0.094 | 0.04 | 0.07 | 0.5 |
| 339 | Major Histocompatibility Complex | 1 | 167 | 10594 | 17750063 | 0.095 | 0.01 | 0.00 | 10.0 |
| 340 | Neural Networks (Computer) | 1 | 167 | 10623 | 17750034 | 0.096 | 0.01 | 0.00 | 10.0 |
| 341 | Cell Line, Tumor | 2 | 166 | 54977 | 17705680 | 0.096 | 0.01 | 0.00 | 3.8 |
| 342 | Biometry | 1 | 167 | 10726 | 17749931 | 0.097 | 0.01 | 0.00 | 9.9 |
| 343 | Lactones | 1 | 167 | 10727 | 17749930 | 0.097 | 0.01 | 0.00 | 9.9 |
| 344 | Immunoenzyme Techniques | 2 | 166 | 55132 | 17705525 | 0.097 | 0.01 | 0.00 | 3.8 |
| 345 | Microscopy, Immunoelectron | 1 | 167 | 10751 | 17749906 | 0.097 | 0.01 | 0.00 | 9.8 |
| 346 | Molecular Sequence Data | 1 | 167 | 489321 | 17271336 | 0.097 | 0.01 | 0.03 | 0.2 |
| 347 | Herpes Simplex | 1 | 167 | 10855 | 17749802 | 0.098 | 0.01 | 0.00 | 9.7 |
| 348 | Tubulin | 1 | 167 | 10931 | 17749726 | 0.098 | 0.01 | 0.00 | 9.7 |
| 349 | Genome, Human | 1 | 167 | 10938 | 17749719 | 0.098 | 0.01 | 0.00 | 9.7 |
| 350 | Receptors, Interleukin-2 | 1 | 167 | 11049 | 17749608 | 0.099 | 0.01 | 0.00 | 9.6 |
| 351 | Mice, Inbred Strains | 2 | 166 | 56107 | 17704550 | 0.099 | 0.01 | 0.00 | 3.8 |
| 352 | Intercellular Signaling Peptides and Proteins | 1 | 167 | 11120 | 17749537 | 0.100 | 0.01 | 0.00 | 9.5 |
| 353 | Cell Differentiation | 3 | 165 | 116793 | 17643864 | 0.100 | 0.02 | 0.01 | 2.7 |
| 354 | Infant | 1 | 167 | 518855 | 17241802 | 0.101 | 0.01 | 0.03 | 0.2 |
| 355 | Fundus Oculi | 1 | 167 | 11293 | 17749364 | 0.101 | 0.01 | 0.00 | 9.4 |
| 356 | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 167 | 11367 | 17749290 | 0.102 | 0.01 | 0.00 | 9.3 |
| 357 | Phospholipases A | 1 | 167 | 11571 | 17749086 | 0.104 | 0.01 | 0.00 | 9.1 |
| 358 | Celiac Disease | 1 | 167 | 11596 | 17749061 | 0.104 | 0.01 | 0.00 | 9.1 |
| 359 | Enzyme Stability | 1 | 167 | 11616 | 17749041 | 0.104 | 0.01 | 0.00 | 9.1 |
| 360 | Adaptor Proteins, Signal Transducing | 1 | 167 | 11625 | 17749032 | 0.104 | 0.01 | 0.00 | 9.1 |
| 361 | Models, Biological | 4 | 164 | 188066 | 17572591 | 0.104 | 0.02 | 0.01 | 2.2 |
| 362 | Tyrosine 3-Monooxygenase | 1 | 167 | 11685 | 17748972 | 0.105 | 0.01 | 0.00 | 9.0 |
| 363 | Receptors, Cholinergic | 1 | 167 | 11741 | 17748916 | 0.105 | 0.01 | 0.00 | 9.0 |
| 364 | Motor Cortex | 1 | 167 | 11779 | 17748878 | 0.106 | 0.01 | 0.00 | 9.0 |
| 365 | Fluorescent Antibody Technique, Indirect | 1 | 167 | 11822 | 17748835 | 0.106 | 0.01 | 0.00 | 8.9 |
| 366 | Cysteine Endopeptidases | 1 | 167 | 11856 | 17748801 | 0.106 | 0.01 | 0.00 | 8.9 |
| 367 | Interleukin-10 | 1 | 167 | 11970 | 17748687 | 0.107 | 0.01 | 0.00 | 8.8 |
| 368 | Narcotics | 1 | 167 | 12088 | 17748569 | 0.108 | 0.01 | 0.00 | 8.7 |
| 369 | Isoquinolines | 1 | 167 | 12306 | 17748351 | 0.110 | 0.01 | 0.00 | 8.6 |
| 370 | Glutamine | 1 | 167 | 12371 | 17748286 | 0.111 | 0.01 | 0.00 | 8.5 |
| 371 | Reperfusion Injury | 1 | 167 | 12464 | 17748193 | 0.111 | 0.01 | 0.00 | 8.5 |
| 372 | Autoantigens | 1 | 167 | 12559 | 17748098 | 0.112 | 0.01 | 0.00 | 8.4 |
| 373 | T-Lymphocytes, Regulatory | 1 | 167 | 12709 | 17747948 | 0.113 | 0.01 | 0.00 | 8.3 |
| 374 | Histocompatibility Antigens Class I | 1 | 167 | 12735 | 17747922 | 0.114 | 0.01 | 0.00 | 8.3 |
| 375 | Intervertebral Disk Displacement | 1 | 167 | 12776 | 17747881 | 0.114 | 0.01 | 0.00 | 8.3 |
| 376 | Communicable Diseases | 1 | 167 | 12788 | 17747869 | 0.114 | 0.01 | 0.00 | 8.3 |
| 377 | Aged | 22 | 146 | 1691547 | 16069110 | 0.115 | 0.13 | 0.10 | 1.4 |
| 378 | Minerals | 1 | 167 | 13095 | 17747562 | 0.117 | 0.01 | 0.00 | 8.1 |
| 379 | Rats, Inbred SHR | 1 | 167 | 13359 | 17747298 | 0.119 | 0.01 | 0.00 | 7.9 |
| 380 | Electrophoresis, Gel, Two-Dimensional | 1 | 167 | 13519 | 17747138 | 0.120 | 0.01 | 0.00 | 7.8 |
| 381 | Weight Loss | 1 | 167 | 13781 | 17746876 | 0.122 | 0.01 | 0.00 | 7.7 |
| 382 | Syphilis | 1 | 167 | 13784 | 17746873 | 0.122 | 0.01 | 0.00 | 7.7 |
| 383 | Disease | 1 | 167 | 13801 | 17746856 | 0.122 | 0.01 | 0.00 | 7.7 |
| 384 | Spectrometry, Mass, Electrospray Ionization | 1 | 167 | 13800 | 17746857 | 0.122 | 0.01 | 0.00 | 7.7 |
| 385 | Tissue Distribution | 2 | 166 | 63891 | 17696766 | 0.123 | 0.01 | 0.00 | 3.3 |
| 386 | Receptors, Cytoplasmic and Nuclear | 1 | 167 | 14062 | 17746595 | 0.125 | 0.01 | 0.00 | 7.5 |
| 387 | Membrane Lipids | 1 | 167 | 14186 | 17746471 | 0.126 | 0.01 | 0.00 | 7.5 |
| 388 | Mesencephalon | 1 | 167 | 14241 | 17746416 | 0.126 | 0.01 | 0.00 | 7.4 |
| 389 | Spinal Diseases | 1 | 167 | 14257 | 17746400 | 0.126 | 0.01 | 0.00 | 7.4 |
| 390 | Injections, Intraventricular | 1 | 167 | 14300 | 17746357 | 0.127 | 0.01 | 0.00 | 7.4 |
| 391 | Cerebrospinal Fluid | 1 | 167 | 14365 | 17746292 | 0.127 | 0.01 | 0.00 | 7.4 |
| 392 | Muscles | 3 | 165 | 131003 | 17629654 | 0.129 | 0.02 | 0.01 | 2.4 |
| 393 | Muscle, Skeletal | 2 | 166 | 66213 | 17694444 | 0.130 | 0.01 | 0.00 | 3.2 |
| 394 | Retroviridae | 1 | 167 | 14891 | 17745766 | 0.131 | 0.01 | 0.00 | 7.1 |
| 395 | Meningitis | 1 | 167 | 14984 | 17745673 | 0.132 | 0.01 | 0.00 | 7.1 |
| 396 | Blood-Brain Barrier | 1 | 167 | 15096 | 17745561 | 0.133 | 0.01 | 0.00 | 7.0 |
| 397 | Arachidonic Acid | 1 | 167 | 15200 | 17745457 | 0.134 | 0.01 | 0.00 | 7.0 |
| 398 | Multienzyme Complexes | 1 | 167 | 15200 | 17745457 | 0.134 | 0.01 | 0.00 | 7.0 |
| 399 | Immunization, Passive | 1 | 167 | 15278 | 17745379 | 0.135 | 0.01 | 0.00 | 6.9 |
| 400 | Interleukin-4 | 1 | 167 | 15289 | 17745368 | 0.135 | 0.01 | 0.00 | 6.9 |
| 401 | Antibodies, Monoclonal | 3 | 165 | 134179 | 17626478 | 0.135 | 0.02 | 0.01 | 2.4 |
| 402 | HLA-DR Antigens | 1 | 167 | 15542 | 17745115 | 0.137 | 0.01 | 0.00 | 6.8 |
| 403 | Spine | 1 | 167 | 15955 | 17744702 | 0.140 | 0.01 | 0.00 | 6.6 |
| 404 | Thalamus | 1 | 167 | 16047 | 17744610 | 0.141 | 0.01 | 0.00 | 6.6 |
| 405 | Clinical Trials as Topic | 3 | 165 | 136876 | 17623781 | 0.141 | 0.02 | 0.01 | 2.3 |
| 406 | Cerebral Infarction | 1 | 167 | 16090 | 17744567 | 0.141 | 0.01 | 0.00 | 6.6 |
| 407 | Intracellular Signaling Peptides and Proteins | 1 | 167 | 16167 | 17744490 | 0.142 | 0.01 | 0.00 | 6.5 |
| 408 | C-Reactive Protein | 1 | 167 | 16194 | 17744463 | 0.142 | 0.01 | 0.00 | 6.5 |
| 409 | Models, Animal | 1 | 167 | 16229 | 17744428 | 0.142 | 0.01 | 0.00 | 6.5 |
| 410 | Capillary Permeability | 1 | 167 | 16356 | 17744301 | 0.143 | 0.01 | 0.00 | 6.5 |
| 411 | AIDS-Related Opportunistic Infections | 1 | 167 | 16382 | 17744275 | 0.144 | 0.01 | 0.00 | 6.5 |
| 412 | Sarcoidosis | 1 | 167 | 16402 | 17744255 | 0.144 | 0.01 | 0.00 | 6.4 |
| 413 | Homeodomain Proteins | 1 | 167 | 16688 | 17743969 | 0.146 | 0.01 | 0.00 | 6.3 |
| 414 | Lymphokines | 1 | 167 | 16706 | 17743951 | 0.146 | 0.01 | 0.00 | 6.3 |
| 415 | Treatment Failure | 1 | 167 | 16742 | 17743915 | 0.147 | 0.01 | 0.00 | 6.3 |
| 416 | Superoxides | 1 | 167 | 16832 | 17743825 | 0.147 | 0.01 | 0.00 | 6.3 |
| 417 | Autonomic Nervous System | 1 | 167 | 17014 | 17743643 | 0.149 | 0.01 | 0.00 | 6.2 |
| 418 | Protease Inhibitors | 1 | 167 | 17225 | 17743432 | 0.150 | 0.01 | 0.00 | 6.1 |
| 419 | Poisoning | 1 | 167 | 17372 | 17743285 | 0.152 | 0.01 | 0.00 | 6.1 |
| 420 | Nitrates | 1 | 167 | 17436 | 17743221 | 0.152 | 0.01 | 0.00 | 6.1 |
| 421 | Neuropeptides | 1 | 167 | 17597 | 17743060 | 0.153 | 0.01 | 0.00 | 6.0 |
| 422 | Proto-Oncogene Proteins c-bcl-2 | 1 | 167 | 17726 | 17742931 | 0.154 | 0.01 | 0.00 | 6.0 |
| 423 | Age of Onset | 1 | 167 | 17823 | 17742834 | 0.155 | 0.01 | 0.00 | 5.9 |
| 424 | Drug Hypersensitivity | 1 | 167 | 17832 | 17742825 | 0.155 | 0.01 | 0.00 | 5.9 |
| 425 | Proteins | 3 | 165 | 143856 | 17616801 | 0.157 | 0.02 | 0.01 | 2.2 |
| 426 | Headache | 1 | 167 | 18027 | 17742630 | 0.157 | 0.01 | 0.00 | 5.9 |
| 427 | Organ Culture Techniques | 1 | 167 | 18079 | 17742578 | 0.157 | 0.01 | 0.00 | 5.8 |
| 428 | Rats, Wistar | 3 | 165 | 144318 | 17616339 | 0.158 | 0.02 | 0.01 | 2.2 |
| 429 | Histocompatibility Antigens Class II | 1 | 167 | 18287 | 17742370 | 0.159 | 0.01 | 0.00 | 5.8 |
| 430 | Body Temperature Regulation | 1 | 167 | 18368 | 17742289 | 0.160 | 0.01 | 0.00 | 5.8 |
| 431 | Adenoviridae | 1 | 167 | 18630 | 17742027 | 0.162 | 0.01 | 0.00 | 5.7 |
| 432 | Peripheral Nerves | 1 | 167 | 19126 | 17741531 | 0.166 | 0.01 | 0.00 | 5.5 |
| 433 | Calcium Channels | 1 | 167 | 19192 | 17741465 | 0.166 | 0.01 | 0.00 | 5.5 |
| 434 | Neurologic Examination | 1 | 167 | 19273 | 17741384 | 0.167 | 0.01 | 0.00 | 5.5 |
| 435 | Protein Isoforms | 1 | 167 | 19479 | 17741178 | 0.168 | 0.01 | 0.00 | 5.4 |
| 436 | Atrophy | 1 | 167 | 19531 | 17741126 | 0.169 | 0.01 | 0.00 | 5.4 |
| 437 | Neuroblastoma | 1 | 167 | 19591 | 17741066 | 0.169 | 0.01 | 0.00 | 5.4 |
| 438 | Trans-Activation (Genetics) | 1 | 167 | 19704 | 17740953 | 0.170 | 0.01 | 0.00 | 5.4 |
| 439 | Crosses, Genetic | 1 | 167 | 19710 | 17740947 | 0.170 | 0.01 | 0.00 | 5.4 |
| 440 | Aged, 80 and over | 6 | 162 | 373623 | 17387034 | 0.173 | 0.04 | 0.02 | 1.7 |
| 441 | Spinal Cord Injuries | 1 | 167 | 20145 | 17740512 | 0.174 | 0.01 | 0.00 | 5.2 |
| 442 | Neovascularization, Pathologic | 1 | 167 | 20248 | 17740409 | 0.174 | 0.01 | 0.00 | 5.2 |
| 443 | Amino Acid Substitution | 1 | 167 | 20395 | 17740262 | 0.176 | 0.01 | 0.00 | 5.2 |
| 444 | Cytoskeleton | 1 | 167 | 20639 | 17740018 | 0.178 | 0.01 | 0.00 | 5.1 |
| 445 | Animals, Newborn | 2 | 166 | 80964 | 17679693 | 0.179 | 0.01 | 0.00 | 2.6 |
| 446 | T-Lymphocytes, Cytotoxic | 1 | 167 | 20924 | 17739733 | 0.180 | 0.01 | 0.00 | 5.1 |
| 447 | Adenosine | 1 | 167 | 21211 | 17739446 | 0.182 | 0.01 | 0.00 | 5.0 |
| 448 | Glutamates | 1 | 167 | 21391 | 17739266 | 0.183 | 0.01 | 0.00 | 4.9 |
| 449 | Respiratory Insufficiency | 1 | 167 | 22351 | 17738306 | 0.191 | 0.01 | 0.00 | 4.7 |
| 450 | Vascular Diseases | 1 | 167 | 22366 | 17738291 | 0.191 | 0.01 | 0.00 | 4.7 |
| 451 | Enzyme Activation | 2 | 166 | 84501 | 17676156 | 0.191 | 0.01 | 0.00 | 2.5 |
| 452 | Cadaver | 1 | 167 | 22497 | 17738160 | 0.192 | 0.01 | 0.00 | 4.7 |
| 453 | Lasers | 1 | 167 | 22592 | 17738065 | 0.193 | 0.01 | 0.00 | 4.7 |
| 454 | Complement System Proteins | 1 | 167 | 22647 | 17738010 | 0.193 | 0.01 | 0.00 | 4.7 |
| 455 | Lymphocyte Activation | 2 | 166 | 85190 | 17675467 | 0.193 | 0.01 | 0.00 | 2.5 |
| 456 | GTP-Binding Proteins | 1 | 167 | 23458 | 17737199 | 0.199 | 0.01 | 0.00 | 4.5 |
| 457 | Reactive Oxygen Species | 1 | 167 | 24199 | 17736458 | 0.205 | 0.01 | 0.00 | 4.4 |
| 458 | Enzyme-Linked Immunosorbent Assay | 2 | 166 | 88604 | 17672053 | 0.205 | 0.01 | 0.00 | 2.4 |
| 459 | Electrochemistry | 1 | 167 | 24340 | 17736317 | 0.206 | 0.01 | 0.00 | 4.3 |
| 460 | Protein Folding | 1 | 167 | 24430 | 17736227 | 0.207 | 0.01 | 0.00 | 4.3 |
| 461 | Injections, Intraperitoneal | 1 | 167 | 24487 | 17736170 | 0.207 | 0.01 | 0.00 | 4.3 |
| 462 | Hypoglycemic Agents | 1 | 167 | 24537 | 17736120 | 0.207 | 0.01 | 0.00 | 4.3 |
| 463 | Corpus Striatum | 1 | 167 | 24638 | 17736019 | 0.208 | 0.01 | 0.00 | 4.3 |
| 464 | Indomethacin | 1 | 167 | 24645 | 17736012 | 0.208 | 0.01 | 0.00 | 4.3 |
| 465 | Administration, Oral | 2 | 166 | 89633 | 17671024 | 0.208 | 0.01 | 0.01 | 2.4 |
| 466 | Gene Deletion | 1 | 167 | 24858 | 17735799 | 0.210 | 0.01 | 0.00 | 4.3 |
| 467 | Peptide Hydrolases | 1 | 167 | 25073 | 17735584 | 0.211 | 0.01 | 0.00 | 4.2 |
| 468 | Safety | 1 | 167 | 25334 | 17735323 | 0.213 | 0.01 | 0.00 | 4.2 |
| 469 | Tumor Suppressor Protein p53 | 1 | 167 | 25525 | 17735132 | 0.215 | 0.01 | 0.00 | 4.1 |
| 470 | Infection | 1 | 167 | 26012 | 17734645 | 0.218 | 0.01 | 0.00 | 4.1 |
| 471 | Severity of Illness Index | 2 | 166 | 93633 | 17667024 | 0.222 | 0.01 | 0.01 | 2.3 |
| 472 | Stem Cells | 1 | 167 | 27143 | 17733514 | 0.227 | 0.01 | 0.00 | 3.9 |
| 473 | Cell Separation | 1 | 167 | 27542 | 17733115 | 0.230 | 0.01 | 0.00 | 3.8 |
| 474 | Transforming Growth Factor beta | 1 | 167 | 27539 | 17733118 | 0.230 | 0.01 | 0.00 | 3.8 |
| 475 | Reflex | 1 | 167 | 27920 | 17732737 | 0.232 | 0.01 | 0.00 | 3.8 |
| 476 | Mortality | 1 | 167 | 28149 | 17732508 | 0.234 | 0.01 | 0.00 | 3.8 |
| 477 | Heterozygote | 1 | 167 | 28325 | 17732332 | 0.235 | 0.01 | 0.00 | 3.7 |
| 478 | Case-Control Studies | 2 | 166 | 97512 | 17663145 | 0.236 | 0.01 | 0.01 | 2.2 |
| 479 | Nitric Oxide Synthase | 1 | 167 | 28683 | 17731974 | 0.238 | 0.01 | 0.00 | 3.7 |
| 480 | Transfection | 2 | 166 | 98657 | 17662000 | 0.240 | 0.01 | 0.01 | 2.1 |
| 481 | Point Mutation | 1 | 167 | 29387 | 17731270 | 0.243 | 0.01 | 0.00 | 3.6 |
| 482 | Treatment Outcome | 5 | 163 | 333705 | 17426952 | 0.252 | 0.03 | 0.02 | 1.6 |
| 483 | Brain Injuries | 1 | 167 | 30678 | 17729979 | 0.252 | 0.01 | 0.00 | 3.4 |
| 484 | Down-Regulation | 1 | 167 | 30748 | 17729909 | 0.253 | 0.01 | 0.00 | 3.4 |
| 485 | Endoscopy | 1 | 167 | 31174 | 17729483 | 0.256 | 0.01 | 0.00 | 3.4 |
| 486 | Cerebellum | 1 | 167 | 32066 | 17728591 | 0.262 | 0.01 | 0.00 | 3.3 |
| 487 | Protein-Serine-Threonine Kinases | 1 | 167 | 32160 | 17728497 | 0.263 | 0.01 | 0.00 | 3.3 |
| 488 | Drug Therapy, Combination | 2 | 166 | 106467 | 17654190 | 0.267 | 0.01 | 0.01 | 2.0 |
| 489 | Follow-Up Studies | 1 | 167 | 360748 | 17399909 | 0.272 | 0.01 | 0.02 | 0.3 |
| 490 | Genetic Markers | 1 | 167 | 33899 | 17726758 | 0.275 | 0.01 | 0.00 | 3.1 |
| 491 | Cytosol | 1 | 167 | 34164 | 17726493 | 0.276 | 0.01 | 0.00 | 3.1 |
| 492 | Pharmaceutical Preparations | 1 | 167 | 34658 | 17725999 | 0.280 | 0.01 | 0.00 | 3.1 |
| 493 | Oxidoreductases | 1 | 167 | 35281 | 17725376 | 0.284 | 0.01 | 0.00 | 3.0 |
| 494 | Protein Conformation | 2 | 166 | 112146 | 17648511 | 0.287 | 0.01 | 0.01 | 1.9 |
| 495 | Functional Laterality | 1 | 167 | 35679 | 17724978 | 0.287 | 0.01 | 0.00 | 3.0 |
| 496 | Immunoglobulins | 1 | 167 | 35713 | 17724944 | 0.287 | 0.01 | 0.00 | 3.0 |
| 497 | Gene Expression Regulation, Developmental | 1 | 167 | 35967 | 17724690 | 0.289 | 0.01 | 0.00 | 2.9 |
| 498 | Bone Marrow Cells | 1 | 167 | 36394 | 17724263 | 0.292 | 0.01 | 0.00 | 2.9 |
| 499 | Nitrogen | 1 | 167 | 36846 | 17723811 | 0.294 | 0.01 | 0.00 | 2.9 |
| 500 | Body Temperature | 1 | 167 | 36958 | 17723699 | 0.295 | 0.01 | 0.00 | 2.9 |
| 501 | Immunization | 1 | 167 | 37010 | 17723647 | 0.296 | 0.01 | 0.00 | 2.9 |
| 502 | Structure-Activity Relationship | 2 | 166 | 115020 | 17645637 | 0.297 | 0.01 | 0.01 | 1.8 |
| 503 | Monocytes | 1 | 167 | 38144 | 17722513 | 0.303 | 0.01 | 0.00 | 2.8 |
| 504 | Interferon Type II | 1 | 167 | 38288 | 17722369 | 0.304 | 0.01 | 0.00 | 2.8 |
| 505 | Reference Values | 2 | 166 | 120106 | 17640551 | 0.314 | 0.01 | 0.01 | 1.8 |
| 506 | Cognition | 1 | 167 | 40135 | 17720522 | 0.316 | 0.01 | 0.00 | 2.6 |
| 507 | Transcription, Genetic | 2 | 166 | 120822 | 17639835 | 0.317 | 0.01 | 0.01 | 1.7 |
| 508 | Necrosis | 1 | 167 | 41583 | 17719074 | 0.326 | 0.01 | 0.00 | 2.5 |
| 509 | Anoxia | 1 | 167 | 42516 | 17718141 | 0.331 | 0.01 | 0.00 | 2.5 |
| 510 | Mutagenesis, Site-Directed | 1 | 167 | 42557 | 17718100 | 0.332 | 0.01 | 0.00 | 2.5 |
| 511 | Blotting, Northern | 1 | 167 | 43003 | 17717654 | 0.334 | 0.01 | 0.00 | 2.5 |
| 512 | Brain Chemistry | 1 | 167 | 43601 | 17717056 | 0.338 | 0.01 | 0.00 | 2.4 |
| 513 | Logistic Models | 1 | 167 | 44186 | 17716471 | 0.342 | 0.01 | 0.00 | 2.4 |
| 514 | Autoantibodies | 1 | 167 | 44484 | 17716173 | 0.344 | 0.01 | 0.00 | 2.4 |
| 515 | Analysis of Variance | 2 | 166 | 129288 | 17631369 | 0.346 | 0.01 | 0.01 | 1.6 |
| 516 | Liver Cirrhosis | 1 | 167 | 44829 | 17715828 | 0.346 | 0.01 | 0.00 | 2.4 |
| 517 | Cell Movement | 1 | 167 | 45634 | 17715023 | 0.351 | 0.01 | 0.00 | 2.3 |
| 518 | Binding, Competitive | 1 | 167 | 45944 | 17714713 | 0.353 | 0.01 | 0.00 | 2.3 |
| 519 | Genetic Vectors | 1 | 167 | 46174 | 17714483 | 0.354 | 0.01 | 0.00 | 2.3 |
| 520 | HIV-1 | 1 | 167 | 46776 | 17713881 | 0.358 | 0.01 | 0.00 | 2.3 |
| 521 | Mass Spectrometry | 1 | 167 | 47738 | 17712919 | 0.364 | 0.01 | 0.00 | 2.2 |
| 522 | Italy | 1 | 167 | 47786 | 17712871 | 0.364 | 0.01 | 0.00 | 2.2 |
| 523 | Drug Synergism | 1 | 167 | 48225 | 17712432 | 0.367 | 0.01 | 0.00 | 2.2 |
| 524 | Middle Aged | 27 | 141 | 2443977 | 15316680 | 0.371 | 0.16 | 0.14 | 1.2 |
| 525 | Lung Diseases | 1 | 167 | 49654 | 17711003 | 0.375 | 0.01 | 0.00 | 2.1 |
| 526 | Diagnosis, Differential | 1 | 167 | 305219 | 17455438 | 0.379 | 0.01 | 0.02 | 0.3 |
| 527 | Pilot Projects | 1 | 167 | 50786 | 17709871 | 0.382 | 0.01 | 0.00 | 2.1 |
| 528 | India | 1 | 167 | 51566 | 17709091 | 0.386 | 0.01 | 0.00 | 2.1 |
| 529 | Dopamine | 1 | 167 | 52204 | 17708453 | 0.390 | 0.01 | 0.00 | 2.0 |
| 530 | Receptors, Cell Surface | 1 | 167 | 52353 | 17708304 | 0.391 | 0.01 | 0.00 | 2.0 |
| 531 | Risk Factors | 1 | 167 | 347532 | 17413125 | 0.391 | 0.01 | 0.02 | 0.3 |
| 532 | Cytoplasm | 1 | 167 | 52827 | 17707830 | 0.394 | 0.01 | 0.00 | 2.0 |
| 533 | Leukocytes | 1 | 167 | 53004 | 17707653 | 0.395 | 0.01 | 0.00 | 2.0 |
| 534 | Staining and Labeling | 1 | 167 | 53974 | 17706683 | 0.400 | 0.01 | 0.00 | 2.0 |
| 535 | Variation (Genetics) | 1 | 167 | 55157 | 17705500 | 0.407 | 0.01 | 0.00 | 1.9 |
| 536 | Hippocampus | 1 | 167 | 60322 | 17700335 | 0.435 | 0.01 | 0.00 | 1.8 |
| 537 | Behavior, Animal | 1 | 167 | 60913 | 17699744 | 0.439 | 0.01 | 0.00 | 1.7 |
| 538 | Neoplasms | 3 | 165 | 199019 | 17561638 | 0.442 | 0.02 | 0.01 | 1.6 |
| 539 | Drug Interactions | 1 | 167 | 64180 | 17696477 | 0.456 | 0.01 | 0.00 | 1.6 |
| 540 | Drug Administration Schedule | 1 | 167 | 64218 | 17696439 | 0.456 | 0.01 | 0.00 | 1.6 |
| 541 | RNA | 1 | 167 | 64910 | 17695747 | 0.459 | 0.01 | 0.00 | 1.6 |
| 542 | Acquired Immunodeficiency Syndrome | 1 | 167 | 67018 | 17693639 | 0.470 | 0.01 | 0.00 | 1.6 |
| 543 | Survival Analysis | 1 | 167 | 67050 | 17693607 | 0.470 | 0.01 | 0.00 | 1.6 |
| 544 | Models, Theoretical | 1 | 167 | 67108 | 17693549 | 0.471 | 0.01 | 0.00 | 1.6 |
| 545 | Electrophysiology | 1 | 167 | 70947 | 17689710 | 0.490 | 0.01 | 0.00 | 1.5 |
| 546 | DNA Primers | 1 | 167 | 75444 | 17685213 | 0.511 | 0.01 | 0.00 | 1.4 |
| 547 | Antibodies | 1 | 167 | 75464 | 17685193 | 0.511 | 0.01 | 0.00 | 1.4 |
| 548 | Regression Analysis | 1 | 167 | 76251 | 17684406 | 0.515 | 0.01 | 0.00 | 1.4 |
| 549 | Fluorescent Antibody Technique | 1 | 167 | 78473 | 17682184 | 0.525 | 0.01 | 0.00 | 1.3 |
| 550 | Promoter Regions (Genetics) | 1 | 167 | 79941 | 17680716 | 0.531 | 0.01 | 0.00 | 1.3 |
| 551 | Retrospective Studies | 1 | 167 | 294839 | 17465818 | 0.536 | 0.01 | 0.02 | 0.4 |
| 552 | Asthma | 1 | 167 | 82841 | 17677816 | 0.544 | 0.01 | 0.00 | 1.3 |
| 553 | Predictive Value of Tests | 1 | 167 | 83354 | 17677303 | 0.546 | 0.01 | 0.00 | 1.3 |
| 554 | Carrier Proteins | 1 | 167 | 85631 | 17675026 | 0.556 | 0.01 | 0.00 | 1.2 |
| 555 | Cerebral Cortex | 1 | 167 | 85868 | 17674789 | 0.557 | 0.01 | 0.00 | 1.2 |
| 556 | Pain | 1 | 167 | 87097 | 17673560 | 0.562 | 0.01 | 0.00 | 1.2 |
| 557 | Time Factors | 5 | 163 | 771660 | 16988997 | 0.567 | 0.03 | 0.04 | 0.7 |
| 558 | Cell Nucleus | 1 | 167 | 90619 | 17670038 | 0.577 | 0.01 | 0.01 | 1.2 |
| 559 | Immunoglobulin G | 1 | 167 | 91466 | 17669191 | 0.580 | 0.01 | 0.01 | 1.2 |
| 560 | HIV Infections | 1 | 167 | 93788 | 17666869 | 0.589 | 0.01 | 0.01 | 1.1 |
| 561 | Bacterial Proteins | 1 | 167 | 96130 | 17664527 | 0.598 | 0.01 | 0.01 | 1.1 |
| 562 | Peptides | 1 | 167 | 100403 | 17660254 | 0.614 | 0.01 | 0.01 | 1.1 |
| 563 | Acute Disease | 2 | 166 | 154322 | 17606335 | 0.660 | 0.01 | 0.01 | 1.4 |
| 564 | Cell Division | 2 | 166 | 161447 | 17599210 | 0.668 | 0.01 | 0.01 | 1.3 |
| 565 | Calcium | 2 | 166 | 207631 | 17553026 | 0.724 | 0.01 | 0.01 | 1.0 |
| 566 | Prospective Studies | 1 | 167 | 240195 | 17520462 | 0.732 | 0.01 | 0.01 | 0.4 |
| 567 | Rats | 10 | 158 | 1199458 | 16561199 | 0.877 | 0.06 | 0.07 | 0.9 |
| 568 | Age Factors | 2 | 166 | 291964 | 17468693 | 1.000 | 0.01 | 0.02 | 0.7 |
| 569 | Lung | 1 | 167 | 147570 | 17613087 | 1.000 | 0.01 | 0.01 | 0.7 |
| 570 | Phenotype | 1 | 167 | 120255 | 17640402 | 1.000 | 0.01 | 0.01 | 0.9 |
| 571 | Prognosis | 2 | 166 | 258065 | 17502592 | 1.000 | 0.01 | 0.01 | 0.8 |
| 572 | Binding Sites | 1 | 167 | 165893 | 17594764 | 1.000 | 0.01 | 0.01 | 0.6 |
| 573 | Chronic Disease | 1 | 167 | 175483 | 17585174 | 1.000 | 0.01 | 0.01 | 0.6 |
| 574 | Cats | 1 | 167 | 112393 | 17648264 | 1.000 | 0.01 | 0.01 | 0.9 |
| 575 | Magnetic Resonance Imaging | 1 | 167 | 172647 | 17588010 | 1.000 | 0.01 | 0.01 | 0.6 |
| 576 | Tomography, X-Ray Computed | 1 | 167 | 194343 | 17566314 | 1.000 | 0.01 | 0.01 | 0.5 |
| 577 | Reproducibility of Results | 1 | 167 | 157534 | 17603123 | 1.000 | 0.01 | 0.01 | 0.7 |
| 578 | Chromatography, High Pressure Liquid | 1 | 167 | 118552 | 17642105 | 1.000 | 0.01 | 0.01 | 0.9 |
| 579 | Anti-Bacterial Agents | 1 | 167 | 174300 | 17586357 | 1.000 | 0.01 | 0.01 | 0.6 |
| 580 | Microscopy, Electron | 1 | 167 | 199801 | 17560856 | 1.000 | 0.01 | 0.01 | 0.5 |
| 581 | Sex Factors | 1 | 167 | 160610 | 17600047 | 1.000 | 0.01 | 0.01 | 0.7 |
| 582 | Temperature | 1 | 167 | 141325 | 17619332 | 1.000 | 0.01 | 0.01 | 0.7 |
| 583 | Electrocardiography | 1 | 167 | 140018 | 17620639 | 1.000 | 0.01 | 0.01 | 0.8 |
| 584 | Myocardial Infarction | 1 | 167 | 113683 | 17646974 | 1.000 | 0.01 | 0.01 | 0.9 |
| 585 | Glucose | 1 | 167 | 106157 | 17654500 | 1.000 | 0.01 | 0.01 | 1.0 |
| 586 | Recombinant Proteins | 1 | 167 | 129881 | 17630776 | 1.000 | 0.01 | 0.01 | 0.8 |